{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:45:02Z","timestamp":1792673102535,"version":"4.5.0"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>We present a diagnostically challenging case of a 51-year-old woman with systemic diffuse large B-cell lymphoma (DLBCL) that progressed to secondary central nervous system (CNS) involvement. The initial presentation was notable for a whole-body PET\/CT scan showing only subtle, diffuse fluorodeoxyglucose uptake in lymph nodes and bone marrow (SUVmax &amp;lt;5.0), below conventional thresholds for malignancy. Four months later, the patient developed an acute encephalopathic illness accompanied by multiorgan dysfunction and a severe hyperinflammatory state consistent with hemophagocytic lymphohistiocytosis. Hallmark laboratory features included refractory lactic acidosis, extreme hyperferritinemia, markedly elevated lactate dehydrogenase, and profound CD4+ lymphopenia. Cranial imaging revealed rapidly progressive, non\u2212specific parenchymal lesions. A definitive diagnosis of the non\u2212germinal center B\u2212cell (non\u2212GCB) subtype of DLBCL was secured via biopsy of a readily accessible facial lymph node\u2014rather than high\u2212risk brain biopsy\u2014illustrating a pivotal diagnostic principle. This case highlights that unexplained persistent lactic acidosis, extreme hyperferritinemia, and even subthreshold PET\/CT findings can be sentinel signs of an underlying aggressive lymphoma. It emphasizes the need for high clinical suspicion and the pursuit of safe, extracranial biopsy sites to enable early diagnosis and intervention in such diagnostically elusive cases.<\/jats:p>","DOI":"10.3389\/fonc.2026.1735699","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T06:42:47Z","timestamp":1772433767000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Deceptive initial presentation of systemic DLBCL with CNS progression following Oligometabolic PET\/CT: case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Rui","family":"Yuan","sequence":"first","affiliation":[{"name":"Department of Critical Care Medicine, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunlan","family":"Long","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyang","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41419-023-06178-0","article-title":"Mir-28-based combination therapy impairs aggressive B cell lymphoma growth by rewiring DNA replication","volume":"14","author":"Fuertes","year":"2023","journal-title":"Cell Death Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.281457","article-title":"Prevention and management of secondary central nervous system lymphoma","volume":"108","author":"Bobillo","year":"2023","journal-title":"Haematologica"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02371-y","article-title":"Identification, risk factors, and clinical course of Cns relapse in Dlbcl patients across 19 prospective phase 2 and 3 trials-a Lysa and Gla\/Dshnhl collaboration","volume":"38","author":"Frontzek","year":"2024","journal-title":"Leukemia"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2008.16.8021","article-title":"Natural history of Cns relapse in patients with aggressive non-Hodgkin\u2019s lymphoma: A 20-year follow-up analysis of Swog 8516 -- the southwest oncology group","volume":"27","author":"Bernstein","year":"2009","journal-title":"J Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003690","article-title":"How I treat neurologic complications in patients with lymphoid cancer","volume":"139","author":"Nayak","year":"2022","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/rlu.0000000000003766","article-title":"Relapsed breast implant-associated anaplastic large-cell lymphoma presenting as refractory fluid collections with low uptake on Fdg Pet\/Ct scan","volume":"46","author":"Alsa\u2019di","year":"2021","journal-title":"Clin Nucl Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.265530","article-title":"Fibroblast activation protein and glycolysis in lymphoma diagnosis: comparison of (68)Ga-Fapi Pet\/Ct and (18)F-Fdg Pet\/Ct","volume":"64","author":"Chen","year":"2023","journal-title":"J Nucl Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/s2352-3026(21)00366-5","article-title":"Malignancy-associated haemophagocytic lymphohistiocytosis","volume":"9","author":"Setiadi","year":"2022","journal-title":"Lancet Haematol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.970183","article-title":"Spectrum and trigger identification of hemophagocytic lymphohistiocytosis in adults: A single-center analysis of 555 cases","volume":"13","author":"Miao","year":"2022","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024027179","article-title":"Modeling the Hlh immune synapse uncovers critical roles for is termination, cytokine intensity, and target cell death","volume":"146","author":"Frank-Kamenetskii","year":"2025","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1007\/s10875-023-01573-w","article-title":"Proteomic analysis of pediatric hemophagocytic lymphohistiocytosis: A comparative study with healthy controls, sepsis, critical ill, and active Epstein-Barr virus infection to identify altered pathways and candidate biomarkers","volume":"43","author":"Li","year":"2023","journal-title":"J Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104928","article-title":"Real-world analysis of primary central nervous system diffuse large B-cell lymphoma","volume":"215","author":"Wang","year":"2025","journal-title":"Crit Rev Oncol Hematol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adk2091","article-title":"Irf8-mutant B cell lymphoma evades immunity through a Cd74-dependent deregulation of antigen processing and presentation in Mhcii complexes","volume":"10","author":"Qiu","year":"2024","journal-title":"Sci Adv"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023020168","article-title":"How I treat secondary Cns involvement by aggressive lymphomas","volume":"142","author":"Alderuccio","year":"2023","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002603","article-title":"Type 17 immunity promotes the exhaustion of Cd8(+) T cells in cancer","volume":"9","author":"Kim","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3390\/cancers12020474","article-title":"Biological features and prognostic impact of bone marrow infiltration in patients with diffuse large B-cell lymphoma","volume":"12","author":"Alonso-\u00c1lvarez","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/diseases11010042","article-title":"Primary bone lymphoma: A review of the literature with emphasis on histopathology and histogenesis","volume":"11","author":"Kanavos","year":"2023","journal-title":"Diseases"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-023-00559-7","article-title":"Single-cell landscape of primary central nervous system diffuse large B-cell lymphoma","volume":"9","author":"Liu","year":"2023","journal-title":"Cell Discov"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3390\/cells13121057","article-title":"Tumour microenvironment: the general principles of pathogenesis and implications in diffuse large B cell lymphoma","volume":"13","author":"Sinkarevs","year":"2024","journal-title":"Cells"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024015689","article-title":"Myeloid landscape profiling identifies Dlbcl-specific suppressive macrophages colocalized with blood endothelial cells","volume":"10","author":"Ferrant","year":"2026","journal-title":"Blood Adv"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2025.0048","article-title":"Nccn guidelines\u00ae Insights: B-cell lymphomas 3.2025","volume":"23","author":"Zelenetz","year":"2025","journal-title":"J Natl Compr Canc Netw"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.113436","article-title":"A prospective observational study of real-world treatment and outcome in secondary Cns lymphoma","volume":"196","author":"Habringer","year":"2024","journal-title":"Eur J Cancer"}],"updated-by":[{"DOI":"10.3389\/fonc.2026.2027139","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000}}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1735699\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:49:28Z","timestamp":1792669768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1735699\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":23,"alternative-id":["10.3389\/fonc.2026.1735699"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1735699","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"article-number":"1735699"}}